益佰制药
(600594)
| 流通市值：27.92亿 | | | 总市值：27.92亿 |
| 流通股本：7.84亿 | | | 总股本：7.84亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 358,837,040.95 | 1,862,920,853.13 | 1,446,704,488.11 | 993,123,553.98 |
| 营业总成本 | 374,652,779.96 | 2,001,366,895.95 | 1,507,739,253.7 | 1,008,735,825.93 |
| 其他经营收益 | | | | |
| 营业利润 | -21,904,407.07 | -303,982,173.75 | -89,917,236.75 | -20,844,463.65 |
| 利润总额 | -20,875,480.6 | -311,748,335.7 | -93,016,607.23 | -23,846,317.27 |
| 净利润 | -28,963,288.04 | -335,341,885.11 | -90,629,803.97 | -22,357,904.18 |
| 每股收益 | | | | |
| 其他综合收益 | - | -164,440.9 | -16,696.42 | 13,486.5 |
| 综合收益总额 | -28,963,288.04 | -335,506,326.01 | -90,646,500.39 | -22,344,417.68 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,443,079,324.15 | 1,447,717,750.36 | 1,630,008,215.69 | 1,778,568,674.38 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,955,146,882.67 | 1,994,117,912.4 | 2,208,180,305.89 | 2,273,752,864.1 |
| 资产总计 | 3,398,226,206.82 | 3,441,835,662.76 | 3,838,188,521.58 | 4,052,321,538.48 |
| 流动负债: | | | | |
| 流动负债合计 | 847,950,870.93 | 908,875,452.96 | 868,436,727.78 | 990,815,878.8 |
| 非流动负债: | | | | |
| 非流动负债合计 | 308,634,412.64 | 262,356,234.36 | 454,287,992.74 | 477,739,775.91 |
| 负债合计 | 1,156,585,283.57 | 1,171,231,687.32 | 1,322,724,720.52 | 1,468,555,654.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,158,262,207.32 | 2,187,786,874.36 | 2,403,179,138.28 | 2,469,869,885.4 |
| 股东权益合计 | 2,241,640,923.25 | 2,270,603,975.44 | 2,515,463,801.06 | 2,583,765,883.77 |
| 负债和股东权益合计 | 3,398,226,206.82 | 3,441,835,662.76 | 3,838,188,521.58 | 4,052,321,538.48 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 447,069,789.96 | 2,244,956,178.86 | 1,726,355,642.42 | 1,217,131,510.06 |
| 经营活动现金流出小计 | 401,891,726.59 | 1,988,250,966.52 | 1,522,557,417.08 | 1,046,578,684.38 |
| 经营活动产生的现金流量净额 | 45,178,063.37 | 256,705,212.34 | 203,798,225.34 | 170,552,825.68 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 817,934.59 | 6,988,631.89 | 47,638.89 | 22,486.8 |
| 投资活动现金流出小计 | 7,595,763.13 | 34,992,693.77 | 23,014,738.24 | 13,770,190.21 |
| 投资活动产生的现金流量净额 | -6,777,828.54 | -28,004,061.88 | -22,967,099.35 | -13,747,703.41 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 255,000,000 | 515,999,999.5 | 427,999,999.5 | 402,999,999.5 |
| 筹资活动现金流出小计 | 250,627,961.3 | 818,566,887.27 | 536,137,800.04 | 385,660,119.87 |
| 筹资活动产生的现金流量净额 | 4,372,038.7 | -302,566,887.77 | -108,137,800.54 | 17,339,879.63 |
| 汇率变动对现金及现金等价物的影响 | -7,856.67 | -8,941.59 | -5,033.51 | -5,555.11 |
| 现金及现金等价物净增加额 | 42,764,416.86 | -73,874,678.9 | 72,688,291.94 | 174,139,446.79 |
| 期末现金及现金等价物余额 | 487,897,047.83 | 445,132,630.97 | 591,695,601.81 | 693,146,756.66 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -73,874,678.9 | - | 174,139,446.79 |